Trial intelligence / Profile preview

Impact of Obesity on AI Efficacy in Early Breast Cancer

NCT01758146Phase 3Unknown

Sponsor
Post Graduate Institute of Medical Education and Research
Start
Jan 2012
Primary completion
Jan 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of letrozole in breast cancer, sponsored by Post Graduate Institute of Medical Education and Research. Status: unknown.

02

Drugs

letrozole
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT01758146.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01758146.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call